TowerBrook and CD&R Complete Acquisition of R1 RCM
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 19 2024
0mins
Source: Newsfilter
Acquisition Announcement: R1 RCM Inc. has been acquired by investment funds from TowerBrook Capital Partners and Clayton, Dubilier & Rice for $14.30 per share, totaling approximately $8.9 billion, leading to the cessation of R1's common stock trading on Nasdaq.
Leadership Change: Joe Flanagan has taken over as CEO of R1, succeeding Lee Rivas, and aims to enhance operational excellence and innovation in healthcare revenue management.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
